TET2-Driven Clonal Hematopoiesis and Response to Canakinumab: An Exploratory Analysis of the CANTOS Randomized Clinical Trial.
JAMA Cardiol
; 7(5): 521-528, 2022 05 01.
Article
in En
| MEDLINE
| ID: mdl-35385050
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Dioxygenases
/
Atherosclerosis
/
Antibodies, Monoclonal, Humanized
/
Clonal Hematopoiesis
Type of study:
Clinical_trials
Limits:
Humans
Language:
En
Journal:
JAMA Cardiol
Year:
2022
Document type:
Article
Country of publication:
Estados Unidos